Literature DB >> 26928778

Association of TERT promoter mutations with telomerase expression in melanoma.

Seungjae Lee1, Patricia Opresko2, Alberto Pappo3, John M Kirkwood4, Armita Bahrami1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26928778      PMCID： PMC5248652          DOI： 10.1111/pcmr.12471

Source DB:  PubMed          Journal:  Pigment Cell Melanoma Res        ISSN： 1755-1471            Impact factor:   4.693


× No keyword cloud information.
  12 in total

1.  Cancer. TERT promoter mutations and telomerase reactivation in urothelial cancer.

Authors:  Sumit Borah; Linghe Xi; Arthur J Zaug; Natasha M Powell; Garrett M Dancik; Scott B Cohen; James C Costello; Dan Theodorescu; Thomas R Cech
Journal:  Science       Date:  2015-02-05       Impact factor: 47.728

2.  Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer.

Authors:  Robert J A Bell; H Tomas Rube; Alex Kreig; Andrew Mancini; Shaun D Fouse; Raman P Nagarajan; Serah Choi; Chibo Hong; Daniel He; Melike Pekmezci; John K Wiencke; Margaret R Wrensch; Susan M Chang; Kyle M Walsh; Sua Myong; Jun S Song; Joseph F Costello
Journal:  Science       Date:  2015-05-14       Impact factor: 47.728

3.  Genomic Classification of Cutaneous Melanoma.

Authors: 
Journal:  Cell       Date:  2015-06-18       Impact factor: 41.582

4.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

5.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.

Authors:  Patrick J Killela; Zachary J Reitman; Yuchen Jiao; Chetan Bettegowda; Nishant Agrawal; Luis A Diaz; Allan H Friedman; Henry Friedman; Gary L Gallia; Beppino C Giovanella; Arthur P Grollman; Tong-Chuan He; Yiping He; Ralph H Hruban; George I Jallo; Nils Mandahl; Alan K Meeker; Fredrik Mertens; George J Netto; B Ahmed Rasheed; Gregory J Riggins; Thomas A Rosenquist; Mark Schiffman; Ie-Ming Shih; Dan Theodorescu; Michael S Torbenson; Victor E Velculescu; Tian-Li Wang; Nicolas Wentzensen; Laura D Wood; Ming Zhang; Roger E McLendon; Darell D Bigner; Kenneth W Kinzler; Bert Vogelstein; Nickolas Papadopoulos; Hai Yan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

6.  TERT promoter mutations in familial and sporadic melanoma.

Authors:  Susanne Horn; Adina Figl; P Sivaramakrishna Rachakonda; Christine Fischer; Antje Sucker; Andreas Gast; Stephanie Kadel; Iris Moll; Eduardo Nagore; Kari Hemminki; Dirk Schadendorf; Rajiv Kumar
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

7.  Highly recurrent TERT promoter mutations in human melanoma.

Authors:  Franklin W Huang; Eran Hodis; Mary Jue Xu; Gregory V Kryukov; Lynda Chin; Levi A Garraway
Journal:  Science       Date:  2013-01-24       Impact factor: 47.728

8.  Cancer-associated TERT promoter mutations abrogate telomerase silencing.

Authors:  Kunitoshi Chiba; Joshua Z Johnson; Jacob M Vogan; Tina Wagner; John M Boyle; Dirk Hockemeyer
Journal:  Elife       Date:  2015-07-21       Impact factor: 8.140

9.  The genomic landscape of childhood and adolescent melanoma.

Authors:  Charles Lu; Jinghui Zhang; Panduka Nagahawatte; John Easton; Seungjae Lee; Zhifa Liu; Li Ding; Matthew A Wyczalkowski; Marcus Valentine; Fariba Navid; Heather Mulder; Ruth G Tatevossian; James Dalton; James Davenport; Zhirong Yin; Michael Edmonson; Michael Rusch; Gang Wu; Yongjin Li; Matthew Parker; Erin Hedlund; Sheila Shurtleff; Susana Raimondi; Vadodaria Bhavin; Yergeau Donald; Elaine R Mardis; Richard K Wilson; William E Evans; David W Ellison; Stanley Pounds; Michael Dyer; James R Downing; Alberto Pappo; Armita Bahrami
Journal:  J Invest Dermatol       Date:  2014-09-30       Impact factor: 8.551

10.  Telomerase Expression by Aberrant Methylation of the TERT Promoter in Melanoma Arising in Giant Congenital Nevi.

Authors:  Yiping Fan; Seungjae Lee; Gang Wu; John Easton; Donald Yergeau; Reinhard Dummer; Peter Vogel; John M Kirkwood; Raymond L Barnhill; Alberto Pappo; Armita Bahrami
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551
View more
  8 in total

1.  Single-cell imaging reveals unexpected heterogeneity of telomerase reverse transcriptase expression across human cancer cell lines.

Authors:  Teisha J Rowland; Gabrijela Dumbović; Evan P Hass; John L Rinn; Thomas R Cech
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

Review 2.  Melanocytic nevi and melanoma: unraveling a complex relationship.

Authors:  W E Damsky; M Bosenberg
Journal:  Oncogene       Date:  2017-06-12       Impact factor: 9.867

3.  Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.

Authors:  Perumal Jayaraj; Seema Sen; Kartikey Saxena; Jassika Gupta; Pranjal Vats; Seema Kashyap; Sheetal Chauhan; Neelam Pushker
Journal:  Indian J Ophthalmol       Date:  2022-03       Impact factor: 2.969

4.  Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma.

Authors:  Brittani Seynnaeve; Seungjae Lee; Sumit Borah; Yongseok Park; Alberto Pappo; John M Kirkwood; Armita Bahrami
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

Review 5.  TERT Promoter Mutations and Telomerase in Melanoma.

Authors:  Yuchen Guo; Yi Chen; Lianghui Zhang; Ling Ma; Keyu Jiang; Gang Yao; Lingjun Zhu
Journal:  J Oncol       Date:  2022-07-19       Impact factor: 4.501

6.  TIE-2 Signaling Activation by Angiopoietin 2 On Myeloid-Derived Suppressor Cells Promotes Melanoma-Specific T-cell Inhibition.

Authors:  Amélie Marguier; Caroline Laheurte; Benoît Lecoester; Marine Malfroy; Laura Boullerot; Adeline Renaudin; Evan Seffar; Abhishek Kumar; Charlée Nardin; François Aubin; Olivier Adotevi
Journal:  Front Immunol       Date:  2022-07-22       Impact factor: 8.786

Review 7.  Telomere Maintenance Mechanisms in Cancer.

Authors:  Tiago Bordeira Gaspar; Ana Sá; José Manuel Lopes; Manuel Sobrinho-Simões; Paula Soares; João Vinagre
Journal:  Genes (Basel)       Date:  2018-05-03       Impact factor: 4.096

8.  MiR-138-5p Suppresses Cell Growth and Migration in Melanoma by Targeting Telomerase Reverse Transcriptase.

Authors:  Estefanía Tarazón; Blanca de Unamuno Bustos; Rosa Murria Estal; Gema Pérez Simó; Antonio Sahuquillo Torralba; Javier Simarro; Sarai Palanca Suela; Rafael Botella Estrada
Journal:  Genes (Basel)       Date:  2021-11-30       Impact factor: 4.096
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.